These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 201408)

  • 21. Defective in vitro antibody production to Varicella zoster and other virus antigens in patients with Hodgkin's disease.
    Souhami RL; Babbage J; Sigfusson A
    Clin Exp Immunol; 1983 Aug; 53(2):297-307. PubMed ID: 6309443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cytotoxicity of effector cells of the peripheral blood, lymph nodes and spleen in Hodgkin's disease].
    Blokhina NG; Bykovskaia SN; Kharabadze MV; Kupriianova TA; Agafonov VA
    Biull Eksp Biol Med; 1989 Nov; 108(11):600-3. PubMed ID: 2633827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
    Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
    Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T and B lymphocytes and Reed-Sternberg cells in Hodgkin's disease lymph nodes and spleens.
    Payne SV; Jones DB; Haegert DG; Smith JL; Wright DH
    Clin Exp Immunol; 1976 May; 24(2):280-6. PubMed ID: 1084241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
    Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
    J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The character and function of mononuclear cells in the spleen and peripheral blood in Hodgkin's disease].
    Pick AI; Loven D; Douer D; Kessler H; Weiss H; Duczyminer M; Har-Zahav L
    Harefuah; 1980; 98(10):433-7. PubMed ID: 7005036
    [No Abstract]   [Full Text] [Related]  

  • 30. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
    Björkholm M; Holm G; Askergren J; Mellstedt H
    Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiosensitivity of Hodgkin's disease lymphocytes.
    Baral E; Blomgren H; Rotstein S
    J Clin Lab Immunol; 1981 Mar; 5(2):101-5. PubMed ID: 7218327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic hormonal activity on human peripheral blood lymphocytes, in vitro. I. Reciprocal effect on T and B rosette formation.
    Shoham J; Cohen M; Chandali Y; Avni A
    Immunology; 1980 Oct; 41(2):353-9. PubMed ID: 6969219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease.
    Martelli MF; Velardi A; Rambotti P; Cernetti C; Bertotto A; Spinozzi F; Bracaglia AM; Falini B; Davis S
    Cancer; 1982 Aug; 50(3):490-7. PubMed ID: 7046903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum factor which inhibits E rosette formation in untreated Hodgkin's disease].
    Roncoli B; Migliorati T; Marinone G
    Riv Emoter Immunoematol; 1979; 26(3-4):125-9. PubMed ID: 555031
    [No Abstract]   [Full Text] [Related]  

  • 37. Frequent T4-positive cells with cytolytic activity in spleens of patients with Hodgkin's disease (a clonal analysis).
    Maggi E; Parronchi P; Del Prete G; Ricci M; Bosi A; Moretta L; Romagnani S
    J Immunol; 1986 Feb; 136(4):1516-20. PubMed ID: 3080527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L428.
    Sanders ME; Makgoba MW; Sussman EH; Luce GE; Cossman J; Shaw S
    Cancer Res; 1988 Jan; 48(1):37-40. PubMed ID: 3275493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.
    Timens W; Poppema S
    Am J Pathol; 1985 Sep; 120(3):443-54. PubMed ID: 3898859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.